News
Jazz Pharma has agreed to pay $145 million to settle lawsuits claiming it illegally acted to prevent generic versions of its narcolepsy therapy Xyrem from entering the US market. The lawsuits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results